173
Views
0
CrossRef citations to date
0
Altmetric
PARAGANGLIOMA IN PREGNANCY

Paraganglioma in pregnancy: interdisciplinary management during pregnancy

, , , , , & show all
Pages 567-570 | Received 02 Oct 2018, Accepted 23 Dec 2018, Published online: 21 Feb 2019
 

Abstract

Paragangliomas are tumors that originate from the extra-adrenal neural crest, the incidence of which during pregnancy is not more than two to eight cases per million people per year and are known to be highly morbid. The purpose of this report is to describe the experience and results obtained during management of a primigravida diagnosed with paraganglioma on week 21.2 and received both medical and surgical management with good maternal and perinatal outcomes. This case report evidences the importance of practicing interdisciplinary management of patients with clinical suspicion of paragangliomas or pheochromocytomas during pregnancy at high-complexity centers even in a medium-income country.

摘要

副神经节瘤是起源于肾上腺外神经鞘的肿瘤, 其妊娠期发病率不超过百万分之二到八, 被认为是非常罕见的。本病例报告的目的是:描述一在孕21.2周诊断为副神经节瘤的初产妇, 在妊娠期治疗过程中所获得的经验和结果, 以及有良好母婴结局的内、外科治疗。本病例报告表明, 即使在中等收入国家, 妊娠期对临床怀疑副神经节瘤或嗜铬细胞瘤的患者在妊娠期进行跨学科管理是很重要的。

The Chinese abstracts are translated by Prof. Dr. Xiangyan Ruan and her team: Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.